Invesco Dynamic Biotech & Genome (PBE) Climbed 5.22% or 2.73 To Price $55.07 On Monday


Invesco Dynamic Biotech & Genome (PBE) climbed 5.22% or 2.73 to $55.07. It is close to 10787 shares traded, which is 34.59% compare to the average total volume 31183. The market cap of PBE is $280.86 million. The year to date change is 16.13%. The 52 week price range is from $43.17 to $60.49. Price of PBE have changed -0.93% during last week. It have changed 1.67% over last month, 1.72% over last 3 months, -10.47% over last 6 months and -0.23% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PBE is 50.37. It is -8.53% below current price. The 200-day Moving Averages for PBE is 53.79. It is -2.32% below current price. The 52-week High is 60.49. It is 9.84% from the current price. The 52-week Low is 43.17. It is -21.61% from current price.

There are some statistics of PBE. It is has market cap $280.86 million. The share outstanding is 5.10 million. The average volume is 31183. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PBE is 7.51%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PBE is 3.62%.


Tags:

Share this post